RYAN · Ryan Specialty Holdings, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted Earnings Per Share non-GAAP | $1.22 | Six Months Ended June 30, 2026 | — |
| Adjusted EBITDAC non-GAAP | 326.9M | Q2 2026 | — |
| Adjusted EBITDAC Margin non-GAAP | 32.7% | Six Months Ended June 30, 2026 | — |
| Adjusted Net Income non-GAAP | 198.7M | Q2 2026 | — |
| Capital returned to shareholders | 284.5M | Q2 2026 | — |
| Dividends and distributions | 24.5M | Q2 2026 | — |
| Organic Revenue Growth Rate non-GAAP | 8.9% | Six Months Ended June 30, 2026 | — |
| Capital return to shareholders | $64.8M | Q1 FY2026 | — |
| Adjusted Net Income Margin non-GAAP | 16.5% | Q4 2025 | — |
| Capital return to stockholders and LLC unit holders | 88.1M | Full Year 2025 | — |
| Share repurchase program authorization | 300M | Full Year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Specialty — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RYAN
this stock
Ryan Specialty Holdings, Inc.
|
$10.70B | -19.0% | +21.3% | — | 5.2% |
|
FNF
Fidelity National Financial, Inc.
|
$13.27B | -9.4% | +5.6% | — | 3.4% |
|
FAF
First American Financial Corp
|
$7.54B | +20.2% | +21.6% | 10.2 | 5.8% |
|
AXS
Axis Capital Holdings Ltd
|
$7.46B | -5.5% | +10.2% | 7.6 | 2.7% |
|
ACT
Enact Holdings, Inc.
|
$6.87B | +26.0% | +2.8% | 10.5 | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RYAN | -2.4% | -0.4% | +7.2% | -5.3% | -19.0% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -2.8% | -4.8% | -6.6% | -9.2% | -32.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.